Insulin gene mutations and diabetes

Journal of Diabetes Investigation

Volumn 2, Issue 2, 2011, Pages 92-100

  Nishi, Masahiro ^a   Nanjo, Kishio ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b Nachi Katsuura Spa Hospital   (Japan)

Author keywords

Endoplasmic reticulum stress; Insulin gene mutation; Neonatal diabetes

Indexed keywords

CYSTEINE; INSULIN; LEUCINE; PHENYLALANINE; PROINSULIN; SERINE; VALINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; APOPTOSIS; AUTOIMMUNITY; BIOACCUMULATION; CAUSAL ATTRIBUTION; CELLULAR DISTRIBUTION; CONFORMATIONAL TRANSITION; CORRELATIONAL STUDY; DIABETES MELLITUS; DISORDERS OF HORMONE METABOLISM; DISULFIDE BOND; ENDOPLASMIC RETICULUM STRESS; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; GENE STRUCTURE; HUMAN; HYPERHYPERPROINSULINEMIA; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN GENE; INSULIN SYNTHESIS; MARKER GENE; MATURITY ONSET DIABETES MELLITUS; MUTATIONAL ANALYSIS; NEWBORN DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RESIDUE ANALYSIS; REVIEW; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 79961069131     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/j.2040-1124.2011.00100.x     Document Type: Review

References (94)

1. Tager H, Given B, Baldwin B, et al. A structurally abnormal insulin causing human diabetes. Nature 1979; 281: 122-125.
2. Given BD, Mako ME, Tager HS, et al. Diabetes due to secretion of an abnormal insulin. N Engl J Med1980; 302: 129-135.
3. Haneda M, Chan SJ, Kwok SCM, et al. Studies on mutant human insulin gene: identification and sequence analysis of a gene encoding Ser B24 insulin. Proc Natl Acad Sci USA 1983; 80: 6366-6370.
4. Shoelson S, Fickova M, Haneda M, et al. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proc Natl Acad Sci USA 1983; 80: 7390-7394.
5. Shoelson S, Haneda M, Blix P, et al. Three mutant insulin in man. Nature 1983; 302: 540-543.
6. Nanjo K, Sanke T, Miyano M, et al. Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama). J Clin Invest 1986; 77: 514-519.
7. Sakura H, Iwamoto Y, Sakamoto Y, et al. Structurally abnormal insulin in a diabetic patient: patient characterization of the mutant insulin A3(val-to-leu) isolated from the pancreas. J Clin Invest 1986; 78: 1666-1672.
8. Nanjo K, Miyano M, Kondo M, et al. Insulin Wakayama: familial mutant insulin syndrome in Japan. Diabetologia 1987; 30: 87-92.
9. Gabby KH, Bergenstal RM, Wilff J, et al. Familial hyperproinsulinemia: partial characterization of circulating proinsulin-like material. Proc Natl Acad Sci USA 1979; 76: 2881-2885.
10. Robbins DC, Blix PM, Rubenstein AH, et al. Ahuman proinsulin variant at arginine 65. Nature 1981; 291: 679-681.
11. Robbins DC, Shoelson SE, Rubenstein AH, et al. Familial hyperproinsulinemia: two cohorts secreting indistinguishable type II intermediates of proinsulin conversion. J Clin Invest 1984; 73: 714-719.
12. Gruppuso PA, Gordon P, Kahn CR, et al. Familial hyperpro-insulinemia due to a proposed defects in conversion of proinsulin to insulin. N Engl J Med 1984; 311: 629-634.
13. Shibasaki Y, Kawakami T, Kanazawa Y, et al. Posttransla-tional cleavage of proinsulin is blocked by a point mutation in familial hyperproinsulinemia. J Clin Invest 1985; 76: 378-380.
14. Yano H, Kitano N, Morimoto M, et al. A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (proinsulin Kyoto). J Clin Invest 1992; 89: 1902-1907.
15. Oohashi H, Ohgawara H, Nanjo K, et al. Familial hyperproinsulinemia associated with NIDDM. Diabetes Care 1993; 16: 1340-1346.
16. Roder ME, Vissing H, Nauck MA. Hyperproinsulinemia in a three-generation Caucasian family due to mutant proinsulin (Arg65->His) not associated with impaired glucose tolerance: the contribution of mutant proinsulin to insulin bioactivity. J Clin Endocrinol Metab 1996; 81: 1634-1640.
17. Warren-Perry MG, Manley SE, Ostrega D, et al. A novel point mutation in the insulin gene giving rise to hyperproinsulinemia. J Clin Endocrinol Metab 1997; 82: 1629-1631.
18. Yoshioka M, Kayo T, Ikeda T, et al. A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice. Diabetes 1997; 46: 887-894.
19. Kayo T, Koizumi A. Mapping of murine diabetogenic gene Mody on chromosome 7 at D7Mit258 and its involvement in pancreatic islet and b cell development during the perinatal period. J Clin Invest 1998; 101: 2112-2118.
20. Wang J, Takeuchi T, Tanaka S, et al. A mutation in the insulin 2 gene induces diabetes with severe pancreatic b-cell dysfunction in the Mody mouse. J Clin Invest 1999; 103: 27-37.
21. C95S mutant mice. Diabetes 2007; 56: 1268-1276.
22. Stoy J, Edghill EL, Flanagan SE, et al. Insulin gene mutations as a cause of permanent neonatal diabetes. Proc Natl Acad Sci USA 2007; 104: 15040-15044.
23. Edghill EL, Flanagan SE, Patch A-M, et al. Insulin mutation screening in 1044 patients with diabetes. Diabetes 2008; 57: 1034-1042.
24. Polak M, Decaume A, Cave H, et al. Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy. Diabetes 2008; 57: 1115-1119.
25. Molven A, Ringdal M, Nordbo AM, et al. Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes. Diabetes 2008; 57: 1131-1135.
26. Colombo C, Porzio O, Liu M, et al. Seven mutations in the human insulin gene linked to permanent neonatal/infancy-onset diabetes mellitus. J Clin Invest 2008; 118: 2148-2156.
27. Bonfanti R, Columbo C, Nocerino V, et al. Insulin gene mutations as cause of diabetes in children negative for five type 1 diabetes autoantibodies. Diabetes Care 2009; 32: 123-125.
28. Rubio-Cabezas O, Edghill EL, Argente J, et al. Testing for monogenic diabetes among children and adolescents with antibody-negative clinically defined type 1 diabetes. Diabet Med 2009; 26: 1070-1074.
29. Ahamed A, Unnikrishnan AG, Pendsey SS, et al. Permanent neonatal diabetes mellitus due to a C96Y heterozygous mutation in the insulin gene. A case report. J Pancreas2008; 9: 715-718.
30. Meur G, Simon A, Harun N, et al. Insulin gene mutations resulting in early-onset diabetes: marked difference in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention. Diabetes 2010; 59: 653-661.
31. Boesgaard TW, Pruhova S, Andersson EA, et al. Further evidence that mutations in INS can be a rare cause of Maturity-Onset Diabetes of the Young (MODY). BMC Med Genet 2010; 11: 42.
32. Garin I, Edghill EL, Akerman I, et al. Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis. Proc Natl Acad Sci USA 2010; 107: 3105-3110.
33. Bell Gi, Pictet RL, Rutter WJ, et al. Sequence of the human insulin gene. Nature 1980; 284: 26-32.
34. Lomedico P, Rosenthal N, Efstratiadis A, et al. The structure and evolution of the two non-allelic rat preproinsulin genes. Cell 1979; 18: 545-558.
35. Steiner DF, Oyer PE. The biosynthesis of insulin and probable precursor of insulin by a human islet cell adenoma. Proc Natl Acad Sci USA 1967; 57: 473-480.
36. Steiner DF, Cunningham D, Spigelman L, et al. Insulin biosynthesis: evidence for a precursor. Science 1967; 157: 697-700.
37. Steiner DF, Bell GI, Rubenstein AH, et al. Chemistry and biosynthesis of the islet hormones: insulin, islet amyloid polypeptide (amylin), glucagon, somatostatin, and pancreatic polypeptide. In: DeGroot LG (ed.). Endocrinology, 14th edn. vol. 1. WB Sannders, Philadelphia, 2001; 667-696.
38. Rhodes CJ, Shoelson S, Halban PA. Insulin biosynthesis, processing, and chemistry. In: Kahn CR (ed.). Joslin's Diabetes Mellitus, 14th edn. Lippincott Williams & Wilkins, Philadelphia. 2005:65-82.
39. Steiner DF, Park S-Y, Stoy J, et al. A brief perspective on insulin production. Diabetes Obes Metab 2009; 11(Suppl 4): 189-196.
40. Weiss MA. Proinsulin and the genetics of diabetes mellitus. J Biol Chem 2009; 284: 19159-19163.
41. Steiner DF, Tager HS, Chan SJ, et al. Lessons learned from molecular biology of insulin-gene mutations. Diabetes Care 1990; 13: 600-609.
42. Nanjo K, Kondo M, Sanke T, et al. Abnormal insulinemia. Diabetes Res Clin Pract 1994; 24(Suppl.): S135-S141.
43. Yamamoto R, Iwamoto Y, Sakura H, et al. Reduced urinary insulin clearance in patients with abnormal insulinemia. Diabetes 1987; 36: 602-606.
44. Hanabusa T, Oki C, Nakano Y, et al. The renal metabolism of insulin: urinary excretion in patients with mutant insulin syndrome (Insulin Wakayama). Metabolism 2001; 50: 863-867.
45. Carroll RJ, Hammer RE, Chan SJ, et al. Amutanthuman proinsulin is secreted from islets of Langerhans in increased amounts via an unregulated pathway. Proc Natl Acd Sci USA 1988; 85: 8943-8947.
46. Gross DJ, Halban PA, Kahn RC, et al. Partial diversion of a mutant proinsulin (B10 aspartic acid) from the regulated to the constitutive secretory pathways in transfected AtT-20 cells. Proc Natl Acad Sci USA 1989; 86: 4107-4111.
47. Schwartz GP, Burke SGT, Katsoyannis PG. A superactive insulin:[B10-aspartic acid] insulin (human). Proc Natl Acad Sci USA 1987; 84: 6408-6411.
48. Leroux L, Desbois P, Lamotte L, et al. Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 2001; 50(Suppl 1): S150-S153.
49. Oyadomari S, Koizumi A, Takeda K, et al. Targeted disruption of the Chop gene delays endoplasmic reticulum stressmediated diabetes. J Clin Invest 2002; 109: 525-532.
50. Izumi T, Yokota-Hashimoto H, Zhao S, et al. Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes 2003; 52: 409-416.
51. Allen JR, Nguyen LX, Sargent KEG, et al. High ER stress in b-cells stimulates intracellular degradation of misfolded insulin. Biochem Biophys Res Commun 2004; 324: 166-170.
52. Oyadomari S, Araki E, Mori M. Endoplasmic reticulum stressmediated apoptosis in pancreatic b-cells. Apoptosis 2002; 7: 335-342.
53. Araki E, Oyadomari S, Mori M. Impact of endoplasmic reticulum stress pathway on pancreatic b-cells and diabetes mellitus. Exp Biol Med 2003; 228: 1213-1217.
54. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008; 29: 42-61.
55. Scheuner D, Kaufman RJ. The unfolded protein response: a pathway that links insulin demand with b-cell failure and diabetes. Endocr Rev 2008; 29: 317-333.
56. Fonseca SG, Burcin M, Gromada J, et al. Endoplasmic reticulum stress in b-cells and development of diabetes. Curr Opin Pharmacol 2009; 9: 763-770.
57. Thomas SE, Dalton LE, Daly M-L, et al. Diabetes as a disease of endoplasmic reticulum stress. Diabetes Metab Res Rev 2010; 26: 611-621.
58. Aguilar-Bryan L, Bryan J. Neonatal diabetes. Endocr Rev 2008; 29: 265-291.
59. Greeley SAW, Tucker SE, Naylor RN, et al. Neonatal diabetes mellitus: A model for personalized medicine. Trends Endocrinol Metab 2010; 21: 464-472.
60. Temple IK, Shield JP. Transient neonatal diabetes, a disorder of imprinting. J Med Genet 2002; 39: 872-875.
61. Glaser G. Insulin mutations in diabetes. The clinical spectrum. Diabetes 2008; 57: 799-800.
62. Yorifuji T, Kurokawa K, Mamada M, et al. Neonatal diabetes and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1b gene due to germline mozaicism. J Clin Endocrinol Metab 2004; 89: 2905-2908.
63. Edghill EL, Bingham C, Slingerland AS, et al. Hepatocyte nuclear factor-1b mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1b in human pancreatic development. Diabet Med 2006; 23: 1301-1306.
64. Njolstad PR, Sovik O, Cuesta-Munoz A, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med2001; 344: 1588-1592.
65. Njolstad PR, Sagen JV, Bjorkhaug L, et al. Permanent neonatal diabetes caused by glucokinase deficiency: in born error of the glucose-insulin signaling pathway. Diabetes 2003; 52: 2854-2860.
66. Porter JR, Shaw NJ, Barrett TG, et al. Permanent neonatal diabetes in an Asian infant. J Pediatr 2005; 146: 131-133.
67. Stoffers DA, Zinkin NT, Stanojevic V, et al. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997; 15: 106-110.
68. Schwitzgebel VM, Mamin A, Brun T, et al. Agenesis of human pancreas due to decreased half-life of insulin promoter factor-1. J Clin Endocrinol Metab 2003; 88: 4398-4406.
69. Chatila TA, Blaeser F, Ho N, et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J Clin Invest 2000; 106: R75-R81.
70. Wildin RS, Ramsdell F, Peake J, et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 2001; 27: 18-20.
71. Delepine M, Nicolino M, Barrett T, et al. EIF2AK3, encoding translation initiation factor 2-a kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet 2000; 25: 406-409.
72. Sellick GS, Barker KT, Stolte-Dijkstra I, et al. Mutations in PTF1A cause pancreatic and cerebellar agenesis. Nat Genet 2004; 36: 1301-1305.
73. Smith SB, Qu HQ, Taleb N, et al. Rfx6 directs islet formation and insulin production in mice and humans. Nature 2010; 463: 775-780.
74. Senee V, Chelala C, Duchatelet S, et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet 2006; 38: 682-687.
75. Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes 2010; 59: 1937-1947.
76. Cavener DR, Gupta S, McGrath BC. PERK in beta cell biology and insulin biogenesis. Trends Endocrinol Metab 2010; 21: 714-721.
77. Stoy J, Steiner DF, Park S-Y, et al. Clinical and molecular genetics of neonatal diabetes due to mutations in the insulin gene. Rev Endocr Metab Disord 2010; 11: 205-215.
78. Liu M, Hodish I, Haataja L, et al. Proinsulin misfolding and diabetes: mutant INS gene-induced diabetes of youth. Trends Endocrinol Metab 2010; 21: 652-659.
79. Rajan S, Eames SC, Park S-Y, et al. In vitro processing and secretion of mutant insulin proteins that cause permanent neonatal diabetes. Am J Physiol Endocrinol Metab 2010; 298: E403-E410.
80. Park S-Y, Ye H, Steiner DF, et al. Mutant proinsulins associ-ated with neonatal diabetes are retained in the endoplasmic reticulum and not efficiently secreted. Biochem Biophys Res Commun 2010; 391: 1449-1454.
81. Hartley T, Siva M, Lai E, et al. Endoplasmic reticulum stress response in an INS-1 pancreatic b-cell line with inducible expression of a folding-deficient proinsulin. BMC Cell Biol 2010; 11: 59.
82. Hodish I, Liu M, Rajpal G, et al. Misfolded proinsulin affects bystander proinsulin in neonatal diabetes. J Biol Chem 2010; 285: 685-694.
83. Liu M, Haataja L, Wright J, et al. Mutant INS-Gene induced diabetes of youth:proinsulin cysteine residues impose dominant-negative inhibition on wild-type proinsulin transport. PLoS ONE 2010; 5: e13333.
84. Bell GI, Selby MJ, Rutter WJ. The highly polymorphic region near the insulin gene is composed of simple tandemly repeating sequences. Nature 1982; 295: 31-35.
85. Bell GI, Horita S, Karam JH. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 1984; 33: 176-183.
86. Julier C, Hyer RN, Davies J, et al. Insulin-IGF2 region on chromosome 11p encodes a gene impricated in HLA-DR4-dependent diabetes susceptibility. Nature 1991; 354: 155-159.
87. Lucassen AM, Julier C, Beressi JP, et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1kbsegement of DNA spanning the insulin gene and associated with VNTR. Nat Genet 1993; 4: 305-310.
88. Bennett ST, Luccassen AM, Gough SC, et al. Susceptibility to type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet 1995; 9: 284-292.
89. Awata T, Kawasaki E, Ikegami H, et al. Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes. J Clin Endocrinol Metab 2007; 92: 1791-1795.
90. Heath VL, Moore NC, Parnell SM, et al. Intrathymic expression of genes involved in organ specific autoimmune disease. J Autoimmun 1998; 11: 309-318.
91. Derbinski J, Schulte A, Kyewski B, et al. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001; 2: 1031-1039.
92. Vafiadis P, Bennett ST, Todd JA, et al. Insulin expression in the thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 1997; 15: 289-292.
93. Pugliese A, Zeller M, Fernandez AJ, et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 1997; 15: 293-297.
94. French MB, Allison J, Cram AS, et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 1997; 46: 34-39.